Nlrp3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The NLRP3 (NLR Family Pyrin Domain Containing 3) gene encodes a key component of the inflammasome complex that plays a critical role in innate immunity and neuroinflammation.
| Property | Value |
|---|---|
| Gene Symbol | NLRP3 |
| Full Name | NLR Family Pyrin Domain Containing 3 |
| Chromosomal Location | 1q44 |
| NCBI Gene ID | 114548 |
| OMIM | 606416 |
| Ensembl ID | ENSG00000162711 |
| UniProt | Q96P20 |
NLRP3 encodes a pattern recognition receptor that forms the NLRP3 inflammasome, a multiprotein complex that activates caspase-1 and leads to the maturation of pro-inflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome is activated by:
NLRP3 inflammasome activation in microglia contributes to chronic neuroinflammation in AD. Aβ oligomers and fibrils can activate NLRP3, leading to IL-1β release that promotes tau pathology and synaptic loss[1].
NLRP3 activation in microglia is observed in PD brains and animal models. α-Synuclein aggregates can activate the NLRP3 inflammasome, contributing to dopaminergic neuron death[2].
NLRP3 inflammasome activation has been implicated in ALS pathogenesis, with increased IL-1β levels in CSF and motor cortex of ALS patients[3].
NLRP3 polymorphisms are associated with MS susceptibility. The inflammasome contributes to demyelination and disease progression[4].
NLRP3 is highly expressed in:
Brain regions with high NLRP3 expression include the substantia nigra, hippocampus, and cortex.
| Approach | Agent | Status | Notes |
|---|---|---|---|
| NLRP3 Inhibitor | MCC950 | Preclinical | Potent inhibitor, blocks IL-1β production |
| NLRP3 Inhibitor | Dapansutrile (OLT1177) | Phase II | Oral small molecule, safety established |
| IL-1β Antibody | Canakinumab | Approved | Targets downstream of NLRP3 |
| IL-1R Antagonist | Anakinra | Approved | Blocks IL-1β signaling |
The study of Nlrp3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Last updated: 2026-03-04